307 related articles for article (PubMed ID: 21718094)
1. Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetes.
Thrailkill KM; Moreau CS; Swearingen C; Rettiganti M; Edwards K; Morales AE; Kemp SF; Frindik JP; Fowlkes JL
Diabetes Technol Ther; 2011 Oct; 13(10):1023-30. PubMed ID: 21718094
[TBL] [Abstract][Full Text] [Related]
2. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
[TBL] [Abstract][Full Text] [Related]
3. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study.
Buse JB; Kudva YC; Battelino T; Davis SN; Shin J; Welsh JB
Diabetes Technol Ther; 2012 Jul; 14(7):644-7. PubMed ID: 22524549
[TBL] [Abstract][Full Text] [Related]
4. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
[No Abstract] [Full Text] [Related]
5. Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients.
Matejko B; Cyganek K; Katra B; Galicka-Latala D; Grzanka M; Malecki MT; Klupa T
Rev Diabet Stud; 2011; 8(2):254-8. PubMed ID: 22189548
[TBL] [Abstract][Full Text] [Related]
6. Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol.
Boughton C; Allen JM; Tauschmann M; Hartnell S; Wilinska ME; Musolino G; Acerini CL; Dunger PD; Campbell F; Ghatak A; Randell T; Besser R; Trevelyan N; Elleri D; Northam E; Hood K; Scott E; Lawton J; Roze S; Sibayan J; Kollman C; Cohen N; Todd J; Hovorka R;
BMJ Open; 2020 Mar; 10(3):e033500. PubMed ID: 32169925
[TBL] [Abstract][Full Text] [Related]
7. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
Hermanides J; Nørgaard K; Bruttomesso D; Mathieu C; Frid A; Dayan CM; Diem P; Fermon C; Wentholt IM; Hoekstra JB; DeVries JH
Diabet Med; 2011 Oct; 28(10):1158-67. PubMed ID: 21294770
[TBL] [Abstract][Full Text] [Related]
8. Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial.
Lawson ML; Verbeeten KC; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Chan J; Tang K
Pediatr Diabetes; 2021 Mar; 22(2):279-287. PubMed ID: 33098212
[TBL] [Abstract][Full Text] [Related]
9. The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.
Conget I; Battelino T; Giménez M; Gough H; Castañeda J; Bolinder J;
Diabetes Technol Ther; 2011 Jan; 13(1):49-54. PubMed ID: 21175271
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of early intensive therapy on β-cell preservation in type 1 diabetes.
Buckingham B; Beck RW; Ruedy KJ; Cheng P; Kollman C; Weinzimer SA; DiMeglio LA; Bremer AA; Slover R; Tamborlane WV; ;
Diabetes Care; 2013 Dec; 36(12):4030-5. PubMed ID: 24130350
[TBL] [Abstract][Full Text] [Related]
11. Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
McVean J; Forlenza GP; Beck RW; Bauza C; Bailey R; Buckingham B; DiMeglio LA; Sherr JL; Clements M; Neyman A; Evans-Molina C; Sims EK; Messer LH; Ekhlaspour L; McDonough R; Van Name M; Rojas D; Beasley S; DuBose S; Kollman C; Moran A;
JAMA; 2023 Mar; 329(12):980-989. PubMed ID: 36826834
[TBL] [Abstract][Full Text] [Related]
12. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
[TBL] [Abstract][Full Text] [Related]
13. Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy.
Olivier P; Lawson ML; Huot C; Richardson C; Nakhla M; Romain J
J Diabetes Sci Technol; 2014 May; 8(3):523-8. PubMed ID: 24876616
[TBL] [Abstract][Full Text] [Related]
14. Comparing Insulin Pump Devices in Real Life: The AWeSoMe Study Group Prospective Experience.
Rachmiel M; Levy-Shraga Y; Gruber N; Pinhas-Hamiel O; Barash G; Pivko-Levy D; Landau Z
Diabetes Technol Ther; 2019 Mar; 21(3):138-145. PubMed ID: 30702335
[TBL] [Abstract][Full Text] [Related]
15. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS).
Little SA; Leelarathna L; Walkinshaw E; Tan HK; Chapple O; Lubina-Solomon A; Chadwick TJ; Barendse S; Stocken DD; Brennand C; Marshall SM; Wood R; Speight J; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JA
Diabetes Care; 2014 Aug; 37(8):2114-22. PubMed ID: 24854041
[TBL] [Abstract][Full Text] [Related]
16. Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.
Halbron M; Bourron O; Andreelli F; Ciangura C; Jacqueminet S; Popelier M; Bosquet F; Rouanet S; Amouyal C; Hartemann A
Diabetes Technol Ther; 2019 Jul; 21(7):409-412. PubMed ID: 31265349
[TBL] [Abstract][Full Text] [Related]
17. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
18. Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.
Zucchini S; Scipione M; Balsamo C; Maltoni G; Rollo A; Molinari E; Mangoni L; Cicognani A
Diabetes Technol Ther; 2011 Dec; 13(12):1187-93. PubMed ID: 21854193
[TBL] [Abstract][Full Text] [Related]
19. IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS.
Vigersky RA; Huang S; Cordero TL; Shin J; Lee SW; Chhabra H; Kaufman FR; Cohen O;
Endocr Pract; 2018 May; 24(5):446-452. PubMed ID: 29847166
[TBL] [Abstract][Full Text] [Related]
20. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
